Gallagher EJ - Search Results

1

Association of Insulin Resistance and Higher Oncotype DX™ Recurrence Score.

Gordon NT, Alberty-Oller JJ, Fei K, Greco G, Gallagher EJ, LeRoith D, Feldman SM, Killilea B, Boolbol SK, Choi L, Friedman N, Pilewskie M, Port E, Tiersten A, Bickell NA. Gordon NT, et al. Among authors: gallagher ej. Ann Surg Oncol. 2021 Oct;28(11):5941-5947. doi: 10.1245/s10434-021-09748-8. Epub 2021 Apr 3. Ann Surg Oncol. 2021. PMID: 33813671

2

Insulin resistance and the metabolic syndrome.

Lann D, Gallagher E, Leroith D. Lann D, et al. Minerva Med. 2008 Jun;99(3):253-62. Minerva Med. 2008. PMID: 18497723 Review.

3

The metabolic syndrome--from insulin resistance to obesity and diabetes.

Gallagher EJ, LeRoith D, Karnieli E. Gallagher EJ, et al. Endocrinol Metab Clin North Am. 2008 Sep;37(3):559-79, vii. doi: 10.1016/j.ecl.2008.05.002. Endocrinol Metab Clin North Am. 2008. PMID: 18775352 Review.

4

Obesity and type 2 diabetes are associated with an increased risk of developing cancer and a worse prognosis; epidemiological and mechanistic evidence.

LeRoith D, Novosyadlyy R, Gallagher EJ, Lann D, Vijayakumar A, Yakar S. LeRoith D, et al. Among authors: gallagher ej. Exp Clin Endocrinol Diabetes. 2008 Sep;116 Suppl 1:S4-6. doi: 10.1055/s-2008-1081488. Epub 2008 Sep 5. Exp Clin Endocrinol Diabetes. 2008. PMID: 18777452 Review.

5

Insulin, insulin resistance, obesity, and cancer.

Gallagher EJ, LeRoith D. Gallagher EJ, et al. Curr Diab Rep. 2010 Apr;10(2):93-100. doi: 10.1007/s11892-010-0101-y. Curr Diab Rep. 2010. PMID: 20425567 Review.

6

The proliferating role of insulin and insulin-like growth factors in cancer.

Gallagher EJ, LeRoith D. Gallagher EJ, et al. Trends Endocrinol Metab. 2010 Oct;21(10):610-8. doi: 10.1016/j.tem.2010.06.007. Epub 2010 Jul 19. Trends Endocrinol Metab. 2010. PMID: 20663687 Free PMC article. Review.

7

The pathway from diabetes and obesity to cancer, on the route to targeted therapy.

Gallagher EJ, Fierz Y, Ferguson RD, LeRoith D. Gallagher EJ, et al. Endocr Pract. 2010 Sep-Oct;16(5):864-73. doi: 10.4158/EP10098.RA. Endocr Pract. 2010. PMID: 20841312 Review.

8

Review of hemoglobin A(1c) in the management of diabetes.

Gallagher EJ, Le Roith D, Bloomgarden Z. Gallagher EJ, et al. J Diabetes. 2009 Mar;1(1):9-17. doi: 10.1111/j.1753-0407.2009.00009.x. Epub 2009 Jan 27. J Diabetes. 2009. PMID: 20923515 Free article. Review.

9

Insulin resistance in obesity as the underlying cause for the metabolic syndrome.

Gallagher EJ, Leroith D, Karnieli E. Gallagher EJ, et al. Mt Sinai J Med. 2010 Sep-Oct;77(5):511-23. doi: 10.1002/msj.20212. Mt Sinai J Med. 2010. PMID: 20960553 Review.

10

Is growth hormone resistance/IGF-1 reduction good for you?

Gallagher EJ, LeRoith D. Gallagher EJ, et al. Cell Metab. 2011 Apr 6;13(4):355-356. doi: 10.1016/j.cmet.2011.03.003. Cell Metab. 2011. PMID: 21459318 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

316 results

Search Page

Filters